mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma
- 22 February 2011
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 50 (5), 338-347
- https://doi.org/10.1002/gcc.20858
Abstract
Translocations or mutations of F US, E WSR1, and T AF15 (FET ) result in distinct genetic diseases. N‐terminal translocations of any FET protein to a series of transcription factors yields chimeric proteins that contribute to sarcomagenesis, whereas mutations in the conserved COOH‐terminal domain of wild‐type FUS were recently shown to cause familial amyotrophic lateral sclerosis. We thus investigated whether the loss of one FUS allele by translocation in liposarcoma may be followed by mutations in either the remaining FUS allele or the paralogous EWSR1 . Furthermore, we investigated the strength of the FET promoters and their contributions to sarcomagenesis given the proteins' frequent involvement in oncogenic translocations. We sequenced the respective genomic regions of both FUS and EWSR1 in 96 liposarcoma samples. Additionally, we determined FET transcript and protein levels in several liposarcoma cell lines. We did not observe sequence variations in either FUS or EWSR1 . However, protein copy numbers reached an impressive 0.9 and 5.5 Mio of FUS and EWSR1 per tumor cell, respectively. Compared with adipose‐derived stem cells, FUS and EWSR1 protein expression levels were elevated on average 28.6‐fold and 7.3‐fold, respectively. TAF15 mRNA levels were elevated on average 3.9‐fold, although with a larger variation between samples. Interestingly, elevated TAF15 mRNA levels did not translate to strongly elevated protein levels, consistent with its infrequent occurrence as translocation partner in tumors. These results suggest that the powerful promoters of FET genes are predominantly responsible for the oncogenic effect of transcription factor translocations in sarcomas.Keywords
This publication has 22 references indexed in Scilit:
- ZIC1 Overexpression Is Oncogenic in LiposarcomaCancer Research, 2010
- FUS‐immunoreactive inclusions are a common feature in sporadic and non‐SOD1 familial amyotrophic lateral sclerosisAnnals of Neurology, 2010
- BioGPS: an extensible and customizable portal for querying and organizing gene annotation resourcesGenome Biology, 2009
- The TET Family of Proteins: Functions and Roles in DiseaseJournal of Molecular Cell Biology, 2009
- Gene Expression Profiling of Liposarcoma Identifies Distinct Biological Types/Subtypes and Potential Therapeutic Targets in Well-Differentiated and Dedifferentiated LiposarcomaCancer Research, 2007
- Origins of chromosome translocations in childhood leukaemiaNature Reviews Cancer, 2003
- The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic miceOncogene, 2000
- Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcomaNature Genetics, 1993
- Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcomaNature, 1993
- The aminoterminal domain of alpha-tubulin probed by monoclonal antibodies. Recognition of a rarely exposed epitope by the monoclonal antibody 111 B52 C2Biology of the Cell, 1988